Additionally, survivin serves as both a diagnosticand prognostic marker, as its high expression correlates with poorerclinical outcomes, higher recurrence rates, and reduced patient survival.Thus, modulating survivin represents a promising therapeutic strategyto improve the effectiveness of breast cancer treatment., This evidence concerns the gene BIRC5 and breast carcinoma.